David R Weber1, Mary B Leonard, Justine Shults, Babette S Zemel. 1. Department of Pediatrics (D.R.W., M.B.L., J.S., B.S.Z.), The Children's Hospital of Philadelphia, and Perelman School of Medicine (M.B.L., J.S., B.S.Z.), University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Abstract
CONTEXT: The use of body mass index (BMI) to assess risk for cardiometabolic disease in the pediatric population may be limited by a failure to differentiate between fat and lean body mass. OBJECTIVES: The objectives of the study were to identify biologically based criteria for the definition of obesity using fat (FMI) and lean body mass index (LBMI) and to compare the ability of FMI and LBMI to BMI to identify the presence of metabolic syndrome (MetSyn). DESIGN: This was a cross-sectional study using National Health and Nutrition Examination Survey 1999-2006 data. PARTICIPANTS: A total of 3004 participants aged 12-20 years with dual-energy X-ray absorptiometry body composition and fasting laboratory data participated in the study. MAIN OUTCOME MEASURES: Adjusted odds ratios for MetSyn according to FMI and LBMI status and area under the curve for the identification of MetSyn were measured. RESULTS: Receiver-operating characteristic curve analyses identified the 80th percentile for FMI and the 74th percentile for LBMI as the optimal cut points for the identification of MetSyn. There was no difference in the area under the curve for FMI [0.867; 95% confidence interval (CI) 0.838-0.891] vs BMI (0.868; 95% CI 0.837-0.894) Z-scores for MetSyn discrimination. Separate multivariate regression models identified odds ratios for the identification of MetSyn of 6.2 (95% CI 3.3-11.5) for BMI-Z, 6.4 (95% CI 3.7-11.1) for FMI-Z, and 4.6 (95% CI 3.0-7.1) for LBMI-Z. Models containing both FMI-Z and LBMI-Z revealed that greater LBMI-Z was associated with greater odds of low high-density lipoprotein (1.5; 95% CI 1.2-1.9), high blood pressure (1.8; 95% CI 1.1-2.9), and insulin resistance (1.8; 95% CI 1.4-2.5), independent of FMI-Z. CONCLUSIONS: The use of FMI and LBMI does not improve upon BMI for the identification of MetSyn in the pediatric population. Unexpectedly, higher LBMI was associated with greater odds of multiple cardiometabolic risk factors independent of FMI. The use of FMI and LBMI allow for the independent evaluation of relationships between body compartments and disease and warrants future research.
CONTEXT: The use of body mass index (BMI) to assess risk for cardiometabolic disease in the pediatric population may be limited by a failure to differentiate between fat and lean body mass. OBJECTIVES: The objectives of the study were to identify biologically based criteria for the definition of obesity using fat (FMI) and lean body mass index (LBMI) and to compare the ability of FMI and LBMI to BMI to identify the presence of metabolic syndrome (MetSyn). DESIGN: This was a cross-sectional study using National Health and Nutrition Examination Survey 1999-2006 data. PARTICIPANTS: A total of 3004 participants aged 12-20 years with dual-energy X-ray absorptiometry body composition and fasting laboratory data participated in the study. MAIN OUTCOME MEASURES: Adjusted odds ratios for MetSyn according to FMI and LBMI status and area under the curve for the identification of MetSyn were measured. RESULTS: Receiver-operating characteristic curve analyses identified the 80th percentile for FMI and the 74th percentile for LBMI as the optimal cut points for the identification of MetSyn. There was no difference in the area under the curve for FMI [0.867; 95% confidence interval (CI) 0.838-0.891] vs BMI (0.868; 95% CI 0.837-0.894) Z-scores for MetSyn discrimination. Separate multivariate regression models identified odds ratios for the identification of MetSyn of 6.2 (95% CI 3.3-11.5) for BMI-Z, 6.4 (95% CI 3.7-11.1) for FMI-Z, and 4.6 (95% CI 3.0-7.1) for LBMI-Z. Models containing both FMI-Z and LBMI-Z revealed that greater LBMI-Z was associated with greater odds of low high-density lipoprotein (1.5; 95% CI 1.2-1.9), high blood pressure (1.8; 95% CI 1.1-2.9), and insulin resistance (1.8; 95% CI 1.4-2.5), independent of FMI-Z. CONCLUSIONS: The use of FMI and LBMI does not improve upon BMI for the identification of MetSyn in the pediatric population. Unexpectedly, higher LBMI was associated with greater odds of multiple cardiometabolic risk factors independent of FMI. The use of FMI and LBMI allow for the independent evaluation of relationships between body compartments and disease and warrants future research.
Authors: Dale A Schoeller; Frances A Tylavsky; David J Baer; William C Chumlea; Carrie P Earthman; Thomas Fuerst; Tamara B Harris; Steven B Heymsfield; Mary Horlick; Timothy G Lohman; Henry C Lukaski; John Shepherd; Roger M Siervogel; Lori G Borrud Journal: Am J Clin Nutr Date: 2005-05 Impact factor: 7.045
Authors: Lisa K Micklesfield; Julia H Goedecke; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly Journal: Obesity (Silver Spring) Date: 2012-01-12 Impact factor: 5.002
Authors: Jacquelyn A Hatch-Stein; Babette S Zemel; Divya Prasad; Heidi J Kalkwarf; Mary Pipan; Sheela N Magge; Andrea Kelly Journal: Pediatrics Date: 2016-09-14 Impact factor: 7.124
Authors: Lauren E Au; Sonya M Zhu; Lilly A Nhan; Kaela R Plank; Edward A Frongillo; Barbara A Laraia; Klara Gurzo; Lorrene D Ritchie Journal: J Nutr Date: 2019-09-01 Impact factor: 4.798
Authors: Grace L Paley; Claire A Sheldon; Evanette K Burrows; Marianne R Chilutti; Grant T Liu; Shana E McCormack Journal: Am J Ophthalmol Date: 2014-11-07 Impact factor: 5.258
Authors: Edward A Frongillo; Stephen B Fawcett; Lorrene D Ritchie; S Sonia Arteaga; Catherine M Loria; Russell R Pate; Lisa V John; Warren J Strauss; Maria Gregoriou; Vicki L Collie-Akers; Jerry A Schultz; Andrew J Landgraf; Jyothi Nagaraja Journal: Am J Prev Med Date: 2017-07-05 Impact factor: 5.043
Authors: Claire A Sheldon; Grace L Paley; Rui Xiao; Anat Kesler; Ori Eyal; Melissa W Ko; Chantal J Boisvert; Robert A Avery; Vincenzo Salpietro; Paul H Phillips; Gena Heidary; Shana E McCormack; Grant T Liu Journal: Ophthalmology Date: 2016-09-28 Impact factor: 12.079
Authors: Line Sletner; Pamela Mahon; Sarah R Crozier; Hazel M Inskip; Keith M Godfrey; Scott Chiesa; Devina J Bhowruth; Marietta Charakida; John Deanfield; Cyrus Cooper; Mark Hanson Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Bowen Xie; Jesus I Avila; Bennett K Ng; Bo Fan; Victoria Loo; Vicente Gilsanz; Thomas Hangartner; Heidi J Kalkwarf; Joan Lappe; Sharon Oberfield; Karen Winer; Babette Zemel; John A Shepherd Journal: Med Phys Date: 2015-08 Impact factor: 4.071
Authors: Jeffrey D Roizen; Jennifer Danzig; Veronique Groleau; Shana McCormack; Alex Casella; Jennifer Harrington; Etienne Sochett; Andrew Tershakovec; Babette S Zemel; Virginia A Stallings; Michael A Levine Journal: J Clin Endocrinol Metab Date: 2015-12-28 Impact factor: 5.958
Authors: Babette S Zemel; Mary Pipan; Virginia A Stallings; Waynitra Hall; Kim Schadt; David S Freedman; Phoebe Thorpe Journal: Pediatrics Date: 2015-11 Impact factor: 7.124